{"transactions":[{"id":744601,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T20:15:12.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":16000,"derivative":{"exercise_price":6.04,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001745995-26-000002","document":"form4-06092026_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000174599526000002/form4-06092026_040608.xml","form_type":"4"}},{"id":1117869,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:45:21.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-016290","document":"form4-06092025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588925016290/form4-06092025_040607.xml","form_type":"4"}},{"id":1183412,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:32:51.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":17502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total shares subject to the option shall vest on March 31, 2026, and 1/36th of the total shares subject to the option shall vest in 24 monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":17502,"derivative":{"exercise_price":0.44,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":17502},"source":{"system":"sec-edgar","filing":"0001415889-25-009654","document":"form4-04022025_080448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588925009654/form4-04022025_080448.xml","form_type":"4"}},{"id":2744659,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T16:52:55.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":244300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of three years with one-third of the shares of common stock underlying the option vesting on April 15, 2022 and the remainder vesting in 8 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan."}],"balance_after":244300,"derivative":{"exercise_price":2.47,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":244300},"source":{"system":"sec-edgar","filing":"0001636050-21-000045","document":"wf-form4_161886555787737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000163605021000045/wf-form4_161886555787737.xml","form_type":"4"}},{"id":2777181,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-19T16:58:34.000Z","date":"2021-03-17","kind":"disposition_to_issuer","acquired":false,"shares":16001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16001},"source":{"system":"sec-edgar","filing":"0001636050-21-000029","document":"wf-form4_161618749134988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000163605021000029/wf-form4_161618749134988.xml","form_type":"4"}},{"id":2777180,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-03-19T16:58:34.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":16001,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25792,"source":{"system":"sec-edgar","filing":"0001636050-21-000029","document":"wf-form4_161618749134988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000163605021000029/wf-form4_161618749134988.xml","form_type":"4"}},{"id":3110063,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T19:38:32.000Z","date":"2020-06-12","kind":"disposition_to_issuer","acquired":false,"shares":16002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. 50% of the common shares underlying the restricted stock units vested on January 31, 2020 but settlement of such portion of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to\nthe Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to\nthe Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":16001,"derivative":{"underlying":"Common Shares","underlying_shares":16002},"source":{"system":"sec-edgar","filing":"0001209191-20-036804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919120036804/doc4.xml","form_type":"4"}},{"id":3110062,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Shares","published_at":"2020-06-15T19:38:32.000Z","date":"2020-06-12","kind":"tax_withholding","acquired":false,"shares":6211,"price":3.46,"value":21490.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold on behalf of the Reporting Person in the open market to cover withholding taxes relating to the settlement of the vested restricted stock units."}],"balance_after":9791,"source":{"system":"sec-edgar","filing":"0001209191-20-036804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919120036804/doc4.xml","form_type":"4"}},{"id":3110061,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Shares","published_at":"2020-06-15T19:38:32.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":16002,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16002,"source":{"system":"sec-edgar","filing":"0001209191-20-036804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919120036804/doc4.xml","form_type":"4"}},{"id":3173677,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Restricted Stock Units","published_at":"2020-04-17T21:04:08.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":42400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the common shares underlying the restricted stock unit shall vest on April 15, 2021, April 15, 2022 and April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the common shares underlying the restricted stock unit shall vest on April 15, 2021, April 15, 2022 and April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":42400,"derivative":{"underlying":"Common Shares","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001209191-20-025017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919120025017/doc4.xml","form_type":"4"}},{"id":3173676,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-17T21:04:08.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":63700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years with 25% of the common shares underlying the option vesting on April 15, 2021 and the remainder vesting in 12 equal quarterly installments thereafter, subject to Reporting Person providing continuous service to the Issuer on each such date.  The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan"}],"balance_after":63700,"derivative":{"exercise_price":3.45,"expiration_date":"2030-04-14","underlying":"Common Shares","underlying_shares":63700},"source":{"system":"sec-edgar","filing":"0001209191-20-025017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919120025017/doc4.xml","form_type":"4"}},{"id":3406744,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Restricted Stock Units","published_at":"2019-09-24T17:15:34.000Z","date":"2019-09-21","kind":"grant","acquired":true,"shares":32003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":32003,"derivative":{"underlying":"Common Shares","underlying_shares":32003},"source":{"system":"sec-edgar","filing":"0001636050-19-000086","document":"wf-form4_156935971860145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000163605019000086/wf-form4_156935971860145.xml","form_type":"4"}},{"id":3553253,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-04-17T21:17:36.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option will vest at such time as the Issuer's 30-day trailing volume weighted average closing stock price (\"30-day VWAP\") is equal to $2.12; one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $4.24; and one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $6.36, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":200000,"derivative":{"exercise_price":1.06,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-025191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919119025191/doc4.xml","form_type":"4"}},{"id":3553252,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-04-17T21:17:36.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":767000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 15, 2020 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":767000,"derivative":{"exercise_price":1.06,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":767000},"source":{"system":"sec-edgar","filing":"0001209191-19-025191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919119025191/doc4.xml","form_type":"4"}},{"id":3863362,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-20T18:23:06.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option will vest at such time as the Issuer's stock price is equal to $7.38; one-third of the option will vest at such time as the Issuer's stock price is equal to $12.30, and one-third of the option will vest at such time as the Issuer's stock price is equal to $17.22, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":200000,"derivative":{"exercise_price":2.46,"expiration_date":"2028-07-16","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-043532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919118043532/doc4.xml","form_type":"4"}},{"id":3863361,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40053,"kind":"person","name":"Corcoran Gavin","position":1,"cik":"0001745995","reported_name":"Corcoran Gavin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-20T18:23:06.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on July 16, 2019 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":250000,"derivative":{"exercise_price":2.46,"expiration_date":"2028-07-16","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-043532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636050/000120919118043532/doc4.xml","form_type":"4"}}]}